|
|||||
|
|
Methylation of Protocadherin 10, a Novel Tumor Suppressor, Is Associated With Poor Prognosis in Patients With Gastric Cancer |
|
| Authors: | Jun Yu Yuen Y. Cheng Qian Tao Kin F. Cheung Cleo N.Y. Lam Hua Geng Lin-Wei Tian Joanna H.M. Tong Jian-Ming Ying Hongchuan Jin Ka F. To Francis K.L. Chan Joseph J.Y. Sung |
| Affiliation: | ? Institute of Digestive Disease and Department of Medicine, The Chinese University of Hong Kong, Shatin, NT, Hong Kong ‡ Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Shatin, NT, Hong Kong § Cancer Epigenetics Laboratory, Department of Clinical Oncology, The Chinese University of Hong Kong, Shatin, NT, Hong Kong # Stanley Ho Center for Emerging Infectious Disease, The Chinese University of Hong Kong, Shatin, NT, Hong Kong ¶ Department of Anatomical and Cellular Pathology, The Chinese University of Hong Kong, Shatin, NT, Hong Kong |
| Abstract: | |
| Keywords: | 5-Aza, 5-Aza-2&prime -deoxycytidine EBV, Epstein-Barr virus PCDH10, protocadherin 10 TSG, tumor-suppressor gene PCR, polymerase chain reaction RR, relative risks |
| 本文献已被 ScienceDirect 等数据库收录！ | |